H1N1pdm Influenza Infection in Hospitalized Cancer Patients: Clinical Evolution and Viral Analysis
Thiago Moreno L. Souza(National Institute of Science and Technology), Marilda Mendonça Siqueira(Fundação Oswaldo Cruz), Fernando Couto Motta(Fundação Oswaldo Cruz), Vasiliy P. Mishin(National Center for Immunization and Respiratory Diseases), Venceslaine Prado Marques(Hospital do Câncer III), Melissa Tassano Pitrowsky(Hospital do Câncer III), Vânia Maria C. Gonçalves(Hospital do Câncer III), Maria de Lourdes Aguiar Oliveira(Fundação Oswaldo Cruz), Jorge I. Salluh(Universidade Federal do Rio de Janeiro), Fernando A. Bozza(D’Or Institute for Research and Education), Sandra Amaral Rocco(Hospital do Câncer III), Larisa V. Gubareva(Centers for Disease Control and Prevention), Anne M. Whitney(Whitney Museum of American Art), Eduardo Velasco(Hospital do Câncer III), Márcio Soares(University of Copenhagen)
Cited by 39
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
|Cell|2022|1k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744